Trial intelligence / Profile preview

Oxytocin maintenance infusion in elective cesarean delivery

NCT04946006Completed

Sponsor
Mount Sinai Hospital
Start
Jul 2021
Primary completion
Apr 2022
Modality
Peptides
Countries
1
01

Overview

Double-blind trial of oxytocin in postpartum hemorrhage (PPH), sponsored by Mount Sinai Hospital. Started Jul 2021; status: completed.

02

Drugs

oxytocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT04946006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04946006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call